Long-term Debt and Lease Obligation of BIO-TECHNE Corp from 30 Jun 2014 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of long-term debt and lease obligation, classified as noncurrent.
Summary
BIO-TECHNE Corp quarterly Long-term Debt and Lease Obligation in USD history and change rate from 30 Jun 2014 to 31 Dec 2025.
  • BIO-TECHNE Corp Long-term Debt and Lease Obligation for the quarter ending 31 Dec 2025 was $260,000,000, a 13% decline year-over-year.
Source SEC data
View on sec.gov
Long-term Debt and Lease Obligation, Quarterly (USD)
Long-term Debt and Lease Obligation, YoY Quarterly Change (%)

BIO-TECHNE Corp Quarterly Long-term Debt and Lease Obligation (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $260,000,000 -$40,000,000 -13% 31 Dec 2025 10-Q 04 Feb 2026 2026 Q2
Q3 2025 $300,000,000 $0 0% 30 Sep 2025 10-Q 05 Nov 2025 2026 Q1
Q2 2025 $346,000,000 +$27,000,000 +8.5% 30 Jun 2025 10-Q 04 Feb 2026 2026 Q2
Q1 2025 $330,000,000 -$59,000,000 -15% 31 Mar 2025 10-Q 08 May 2025 2025 Q3
Q4 2024 $300,000,000 -$147,000,000 -33% 31 Dec 2024 10-Q 06 Feb 2025 2025 Q2
Q3 2024 $300,000,000 -$140,000,000 -32% 30 Sep 2024 10-Q 05 Nov 2024 2025 Q1
Q2 2024 $319,000,000 -$31,000,000 -8.9% 30 Jun 2024 10-K 22 Aug 2025 2025 FY
Q1 2024 $389,000,000 +$19,000,000 +5.1% 31 Mar 2024 10-Q 06 May 2024 2024 Q3
Q4 2023 $447,000,000 +$247,000,000 +124% 31 Dec 2023 10-Q 07 Feb 2024 2024 Q2
Q3 2023 $440,000,000 +$175,339,000 +66% 30 Sep 2023 10-Q 07 Nov 2023 2024 Q1
Q2 2023 $350,000,000 +$106,590,000 +44% 30 Jun 2023 10-K 22 Aug 2024 2024 FY
Q1 2023 $370,000,000 +$123,486,000 +50% 31 Mar 2023 10-Q 08 May 2023 2023 Q3
Q4 2022 $200,000,000 -$69,618,000 -26% 31 Dec 2022 10-Q 07 Feb 2023 2023 Q2
Q3 2022 $264,661,000 -$23,062,000 -8% 30 Sep 2022 10-Q 07 Nov 2022 2023 Q1
Q2 2022 $243,410,000 -$85,417,000 -26% 30 Jun 2022 10-K 23 Aug 2023 2023 FY
Q1 2022 $246,514,000 +$43,583,000 +21% 31 Mar 2022 10-Q 09 May 2022 2022 Q3
Q4 2021 $269,618,000 +$50,583,000 +23% 31 Dec 2021 10-Q 07 Feb 2022 2022 Q2
Q3 2021 $287,723,000 -$23,416,000 -7.5% 30 Sep 2021 10-Q 08 Nov 2021 2022 Q1
Q2 2021 $328,827,000 -$15,416,000 -4.5% 30 Jun 2021 10-K 24 Aug 2022 2022 FY
Q1 2021 $202,931,000 -$204,417,000 -50% 31 Mar 2021 10-Q 07 May 2021 2021 Q3
Q4 2020 $219,035,000 -$151,417,000 -41% 31 Dec 2020 10-Q 08 Feb 2021 2021 Q2
Q3 2020 $311,139,000 -$162,417,000 -34% 30 Sep 2020 10-Q 09 Nov 2020 2021 Q1
Q2 2020 $344,243,000 -$148,417,000 -30% 30 Jun 2020 10-K 25 Aug 2021 2021 FY
Q1 2020 $407,348,000 -$102,417,000 -20% 31 Mar 2020 10-Q 11 May 2020 2020 Q3
Q4 2019 $370,452,000 -$162,417,000 -30% 31 Dec 2019 10-Q 06 Feb 2020 2020 Q2
Q3 2019 $473,556,000 -$75,417,000 -14% 30 Sep 2019 10-Q 06 Nov 2019 2020 Q1
Q2 2019 $492,660,000 +$153,660,000 +45% 30 Jun 2019 10-K 26 Aug 2020 2020 FY
Q1 2019 $509,765,000 +$117,265,000 +30% 31 Mar 2019 10-Q 07 May 2019 2019 Q3
Q4 2018 $532,869,000 +$170,369,000 +47% 31 Dec 2018 10-Q 07 Feb 2019 2019 Q2
Q3 2018 $548,973,000 +$211,473,000 +63% 30 Sep 2018 10-Q 07 Nov 2018 2019 Q1
Q2 2018 $339,000,000 -$4,771,000 -1.4% 30 Jun 2018 10-K/A 06 Nov 2019 2019 FY
Q1 2018 $392,500,000 +$48,863,000 +14% 31 Mar 2018 10-Q 09 May 2018 2018 Q3
Q4 2017 $362,500,000 +$18,841,000 +5.5% 31 Dec 2017 10-Q 08 Feb 2018 2018 Q2
Q3 2017 $337,500,000 -$6,000,000 -1.7% 30 Sep 2017 10-Q 09 Nov 2017 2018 Q1
Q2 2017 $343,771,000 +$252,271,000 +276% 30 Jun 2017 10-K 27 Aug 2018 2018 FY
Q1 2017 $343,637,000 +$185,829,000 +118% 31 Mar 2017 10-Q 10 May 2017 2017 Q3
Q4 2016 $343,659,000 +$180,870,000 +111% 31 Dec 2016 10-Q 09 Feb 2017 2017 Q2
Q3 2016 $343,500,000 +$179,132,000 +109% 30 Sep 2016 10-Q 09 Nov 2016 2017 Q1
Q2 2016 $91,500,000 +$18,500,000 +25% 30 Jun 2016 10-K 07 Sep 2017 2017 FY
Q1 2016 $157,808,000 +$13,808,000 +9.6% 31 Mar 2016 10-Q 10 May 2016 2016 Q3
Q4 2015 $162,789,000 +$18,789,000 +13% 31 Dec 2015 10-Q 09 Feb 2016 2016 Q2
Q3 2015 $164,368,000 +$52,368,000 +47% 30 Sep 2015 10-Q 09 Nov 2015 2016 Q1
Q2 2015 $73,000,000 +$73,000,000 30 Jun 2015 10-K 29 Aug 2016 2016 FY
Q1 2015 $144,000,000 31 Mar 2015 10-Q 11 May 2015 2015 Q3
Q4 2014 $144,000,000 31 Dec 2014 10-Q 09 Feb 2015 2015 Q2
Q3 2014 $112,000,000 30 Sep 2014 10-Q 10 Nov 2014 2015 Q1
Q2 2014 $0 30 Jun 2014 10-K 31 Aug 2015 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.